#escmid2026 — Public Fediverse posts

Finally back home after incredibly impressive two weeks.
At #escmid2026 in Munich we presented our first #NeoIPC Surveillance data and I met a lot of great colleagues we work with.
From there we directly traveled to #Lviv and #IvanoFrankivsk to meet the Friends and Colleagues we collaborate with to exchange ideas and experiences regarding #IPC with support by @GIZ as part of their #HospitalPartnerships program.
I'm thankful for all this support and these wonderful dedicated people in my life ❤

Finally back home after incredibly impressive two weeks.
At #escmid2026 in Munich we presented our first #NeoIPC Surveillance data and I met a lot of great colleagues we work with.
From there we directly traveled to #Lviv and #IvanoFrankivsk to meet the Friends and Colleagues we collaborate with to exchange ideas and experiences regarding #IPC with support by @GIZ as part of their #HospitalPartnerships program.
I'm thankful for all this support and these wonderful dedicated people in my life ❤

Finally back home after incredibly impressive two weeks.
At #escmid2026 in Munich we presented our first #NeoIPC Surveillance data and I met a lot of great colleagues we work with.
From there we directly traveled to #Lviv and #IvanoFrankivsk to meet the Friends and Colleagues we collaborate with to exchange ideas and experiences regarding #IPC with support by @GIZ as part of their #HospitalPartnerships program.
I'm thankful for all this support and these wonderful dedicated people in my life ❤

Finally back home after incredibly impressive two weeks.
At #escmid2026 in Munich we presented our first #NeoIPC Surveillance data and I met a lot of great colleagues we work with.
From there we directly traveled to #Lviv and #IvanoFrankivsk to meet the Friends and Colleagues we collaborate with to exchange ideas and experiences regarding #IPC with support by @GIZ as part of their #HospitalPartnerships program.
I'm thankful for all this support and these wonderful dedicated people in my life ❤

Finally back home after incredibly impressive two weeks.
At #escmid2026 in Munich we presented our first #NeoIPC Surveillance data and I met a lot of great colleagues we work with.
From there we directly traveled to #Lviv and #IvanoFrankivsk to meet the Friends and Colleagues we collaborate with to exchange ideas and experiences regarding #IPC with support by @GIZ as part of their #HospitalPartnerships program.
I'm thankful for all this support and these wonderful dedicated people in my life ❤

Really disappointed that this wasn't a bouncy castle.
#ESCMID #ESCMID2026

Really disappointed that this wasn't a bouncy castle.
#ESCMID #ESCMID2026

Really disappointed that this wasn't a bouncy castle.
#ESCMID #ESCMID2026

Really disappointed that this wasn't a bouncy castle.
#ESCMID #ESCMID2026

Really disappointed that this wasn't a bouncy castle.
#ESCMID #ESCMID2026

A very calm, measured talk today by Dr Arkadii from Ukraine, on the subject of antimicrobial resistance in the setting of conflict.

He described emerging problems with resistance in war wounded, compounded by supply chain issues, staff shortages, waves of overcrowding, and transfer of patients nationally & internationally.

There have been over 3000 attacks on healthcare in Ukraine since the war started.

He ends by quoting Dr Tedros of the WHO: "Peace is the best medicine."
#ESCMID #ESCMID2026

A very calm, measured talk today by Dr Arkadii from Ukraine, on the subject of antimicrobial resistance in the setting of conflict.

He described emerging problems with resistance in war wounded, compounded by supply chain issues, staff shortages, waves of overcrowding, and transfer of patients nationally & internationally.

There have been over 3000 attacks on healthcare in Ukraine since the war started.

He ends by quoting Dr Tedros of the WHO: "Peace is the best medicine."
#ESCMID #ESCMID2026

A very calm, measured talk today by Dr Arkadii from Ukraine, on the subject of antimicrobial resistance in the setting of conflict.

He described emerging problems with resistance in war wounded, compounded by supply chain issues, staff shortages, waves of overcrowding, and transfer of patients nationally & internationally.

There have been over 3000 attacks on healthcare in Ukraine since the war started.

He ends by quoting Dr Tedros of the WHO: "Peace is the best medicine."
#ESCMID #ESCMID2026

A very calm, measured talk today by Dr Arkadii from Ukraine, on the subject of antimicrobial resistance in the setting of conflict.

He described emerging problems with resistance in war wounded, compounded by supply chain issues, staff shortages, waves of overcrowding, and transfer of patients nationally & internationally.

There have been over 3000 attacks on healthcare in Ukraine since the war started.

He ends by quoting Dr Tedros of the WHO: "Peace is the best medicine."
#ESCMID #ESCMID2026

A very calm, measured talk today by Dr Arkadii from Ukraine, on the subject of antimicrobial resistance in the setting of conflict.

He described emerging problems with resistance in war wounded, compounded by supply chain issues, staff shortages, waves of overcrowding, and transfer of patients nationally & internationally.

There have been over 3000 attacks on healthcare in Ukraine since the war started.

He ends by quoting Dr Tedros of the WHO: "Peace is the best medicine."
#ESCMID #ESCMID2026

From nine sessions so far, about 50% of panel chairs have been women. Keep it up!
##ESCMID2026 #ESCMID

From nine sessions so far, about 50% of panel chairs have been women. Keep it up!
##ESCMID2026 #ESCMID

From nine sessions so far, about 50% of panel chairs have been women. Keep it up!
##ESCMID2026 #ESCMID

From nine sessions so far, about 50% of panel chairs have been women. Keep it up!
##ESCMID2026 #ESCMID

From nine sessions so far, about 50% of panel chairs have been women. Keep it up!
##ESCMID2026 #ESCMID

Some fascinating bone and joint infection cases in this session - Bacteroides in a neonate, tularaemia in a rural Spanish patient's hip, and a severe multifocal Burkholderia osteomyelitis in tibia and ankle requiring extensive drainage and debridement.

The last one, exposed through farming in the Philippines, recovered superbly, as shown by a video of him dad dancing with his son, just 12 weeks after surgical drainage.

#ESCMID #ESCMID2026

Some fascinating bone and joint infection cases in this session - Bacteroides in a neonate, tularaemia in a rural Spanish patient's hip, and a severe multifocal Burkholderia osteomyelitis in tibia and ankle requiring extensive drainage and debridement.

The last one, exposed through farming in the Philippines, recovered superbly, as shown by a video of him dad dancing with his son, just 12 weeks after surgical drainage.

#ESCMID #ESCMID2026

Some fascinating bone and joint infection cases in this session - Bacteroides in a neonate, tularaemia in a rural Spanish patient's hip, and a severe multifocal Burkholderia osteomyelitis in tibia and ankle requiring extensive drainage and debridement.

The last one, exposed through farming in the Philippines, recovered superbly, as shown by a video of him dad dancing with his son, just 12 weeks after surgical drainage.

#ESCMID #ESCMID2026

Some fascinating bone and joint infection cases in this session - Bacteroides in a neonate, tularaemia in a rural Spanish patient's hip, and a severe multifocal Burkholderia osteomyelitis in tibia and ankle requiring extensive drainage and debridement.

The last one, exposed through farming in the Philippines, recovered superbly, as shown by a video of him dad dancing with his son, just 12 weeks after surgical drainage.

#ESCMID #ESCMID2026

Some fascinating bone and joint infection cases in this session - Bacteroides in a neonate, tularaemia in a rural Spanish patient's hip, and a severe multifocal Burkholderia osteomyelitis in tibia and ankle requiring extensive drainage and debridement.

The last one, exposed through farming in the Philippines, recovered superbly, as shown by a video of him dad dancing with his son, just 12 weeks after surgical drainage.

#ESCMID #ESCMID2026

Interesting update from EUCAST this morning: there are newer beta-lactamase inhibitors in development which not only break down bacterial enzymes that stop beta-lactam antibiotics (e.g penicillin) from working, but also have direct bactericidal activity against the bacteria. Shield and sword dual wield, in effect. #ESCMID #ESCMID2026

Interesting update from EUCAST this morning: there are newer beta-lactamase inhibitors in development which not only break down bacterial enzymes that stop beta-lactam antibiotics (e.g penicillin) from working, but also have direct bactericidal activity against the bacteria. Shield and sword dual wield, in effect. #ESCMID #ESCMID2026

Interesting update from EUCAST this morning: there are newer beta-lactamase inhibitors in development which not only break down bacterial enzymes that stop beta-lactam antibiotics (e.g penicillin) from working, but also have direct bactericidal activity against the bacteria. Shield and sword dual wield, in effect. #ESCMID #ESCMID2026

Interesting update from EUCAST this morning: there are newer beta-lactamase inhibitors in development which not only break down bacterial enzymes that stop beta-lactam antibiotics (e.g penicillin) from working, but also have direct bactericidal activity against the bacteria. Shield and sword dual wield, in effect. #ESCMID #ESCMID2026

Interesting update from EUCAST this morning: there are newer beta-lactamase inhibitors in development which not only break down bacterial enzymes that stop beta-lactam antibiotics (e.g penicillin) from working, but also have direct bactericidal activity against the bacteria. Shield and sword dual wield, in effect. #ESCMID #ESCMID2026

Patient priorities are vital. For instance, a younger fitter person may not mind some limited side-effects if it gets them out of the hospital and back to work / life more promptly.

A frail older person with little reserve might instead prioritise treatment with the lowest risk of side-effects, which could be more problematic in the long run, even if treatment takes longer.

#ESCMID ##ESCMID2026

Patient priorities are vital. For instance, a younger fitter person may not mind some limited side-effects if it gets them out of the hospital and back to work / life more promptly.

A frail older person with little reserve might instead prioritise treatment with the lowest risk of side-effects, which could be more problematic in the long run, even if treatment takes longer.

#ESCMID ##ESCMID2026

Patient priorities are vital. For instance, a younger fitter person may not mind some limited side-effects if it gets them out of the hospital and back to work / life more promptly.

A frail older person with little reserve might instead prioritise treatment with the lowest risk of side-effects, which could be more problematic in the long run, even if treatment takes longer.

#ESCMID ##ESCMID2026

Patient priorities are vital. For instance, a younger fitter person may not mind some limited side-effects if it gets them out of the hospital and back to work / life more promptly.

A frail older person with little reserve might instead prioritise treatment with the lowest risk of side-effects, which could be more problematic in the long run, even if treatment takes longer.

#ESCMID ##ESCMID2026

Patient priorities are vital. For instance, a younger fitter person may not mind some limited side-effects if it gets them out of the hospital and back to work / life more promptly.

A frail older person with little reserve might instead prioritise treatment with the lowest risk of side-effects, which could be more problematic in the long run, even if treatment takes longer.

#ESCMID ##ESCMID2026

Really interesting session this morning on outcome measurements in antibiotic therapy: mortality, or simple "cure vs not cure" measures are not always useful.

For instance, two patients might be cured with antibiotics, but one might suffer a life-threatening adverse event (e.g. C diff) and spend much longer in hospital, with functional decline and long-term consequences.

Alternative, stratified outcomes are sometimes more helpful.

#ESCMID2026 #ESCMID

Really interesting session this morning on outcome measurements in antibiotic therapy: mortality, or simple "cure vs not cure" measures are not always useful.

For instance, two patients might be cured with antibiotics, but one might suffer a life-threatening adverse event (e.g. C diff) and spend much longer in hospital, with functional decline and long-term consequences.

Alternative, stratified outcomes are sometimes more helpful.

#ESCMID2026 #ESCMID

Really interesting session this morning on outcome measurements in antibiotic therapy: mortality, or simple "cure vs not cure" measures are not always useful.

For instance, two patients might be cured with antibiotics, but one might suffer a life-threatening adverse event (e.g. C diff) and spend much longer in hospital, with functional decline and long-term consequences.

Alternative, stratified outcomes are sometimes more helpful.

#ESCMID2026 #ESCMID

Really interesting session this morning on outcome measurements in antibiotic therapy: mortality, or simple "cure vs not cure" measures are not always useful.

For instance, two patients might be cured with antibiotics, but one might suffer a life-threatening adverse event (e.g. C diff) and spend much longer in hospital, with functional decline and long-term consequences.

Alternative, stratified outcomes are sometimes more helpful.

#ESCMID2026 #ESCMID

Really interesting session this morning on outcome measurements in antibiotic therapy: mortality, or simple "cure vs not cure" measures are not always useful.

For instance, two patients might be cured with antibiotics, but one might suffer a life-threatening adverse event (e.g. C diff) and spend much longer in hospital, with functional decline and long-term consequences.

Alternative, stratified outcomes are sometimes more helpful.

#ESCMID2026 #ESCMID

First speaker in the session on antibiotic sensitivity testing highlights the importance of getting clinicians to supply enough information to guide testing. Or, in his words, "shit in, shit out".

#ESCMID2026 #ESCMID

First speaker in the session on antibiotic sensitivity testing highlights the importance of getting clinicians to supply enough information to guide testing. Or, in his words, "shit in, shit out".

#ESCMID2026 #ESCMID

First speaker in the session on antibiotic sensitivity testing highlights the importance of getting clinicians to supply enough information to guide testing. Or, in his words, "shit in, shit out".

#ESCMID2026 #ESCMID

First speaker in the session on antibiotic sensitivity testing highlights the importance of getting clinicians to supply enough information to guide testing. Or, in his words, "shit in, shit out".

#ESCMID2026 #ESCMID

First speaker in the session on antibiotic sensitivity testing highlights the importance of getting clinicians to supply enough information to guide testing. Or, in his words, "shit in, shit out".

#ESCMID2026 #ESCMID